z-logo
open-access-imgOpen Access
No gains in efficacy observed by adding gemcitabine to adjuvant therapy for lymph node‐positive breast cancer
Author(s) -
Barton Mary Kay
Publication year - 2013
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/caac.21206
Subject(s) - medicine , gemcitabine , oncology , breast cancer , regimen , adjuvant , docetaxel , chemotherapy , randomized controlled trial , adjuvant therapy , lymph node , cyclophosphamide , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom